A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the world workshop on oral …
A Wolff, RK Joshi, J Ekström, D Aframian… - Drugs in R&d, 2017 - Springer
Background Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation
of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of …
of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of …
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder
Children, adolescents and adults with attention-deficit/hyperactivity disorder (ADHD)
experience functional impairment and poor health-related quality of life (HRQoL) in addition …
experience functional impairment and poor health-related quality of life (HRQoL) in addition …
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
JJS Kooij, D Bijlenga, L Salerno, R Jaeschke… - European …, 2019 - cambridge.org
Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …
Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD)
M Pozzi, S Bertella, E Gatti, GGAM Peeters… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental
disorder affecting up to 5.3% of children and 2.5% of adults depending on the country …
disorder affecting up to 5.3% of children and 2.5% of adults depending on the country …
Alternative pharmacological strategies for adult ADHD treatment: a systematic review
M Buoli, M Serati, W Cahn - Expert review of neurotherapeutics, 2016 - Taylor & Francis
ABSTRACT Adult Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent psychiatric
condition associated with high disability and frequent comorbidity. Current standard …
condition associated with high disability and frequent comorbidity. Current standard …
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder
GE Brancati, A Magnesa, D Acierno… - Expert Review of …, 2024 - Taylor & Francis
Introduction Stimulants, including methylphenidate and amphetamines, are the first-line
pharmacological treatment of ADHD in adults. However, in patients who do not respond or …
pharmacological treatment of ADHD in adults. However, in patients who do not respond or …
Urinary side effects of psychotropic drugs: A systematic review and metanalysis
M Trinchieri, G Perletti, V Magri… - Neurourology and …, 2021 - Wiley Online Library
Objective To evaluate the effects of psychotropic drugs on bladder function. Materials and
Methods A systematic review was carried out by searching PubMed and Embase databases …
Methods A systematic review was carried out by searching PubMed and Embase databases …
A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder
A Ghanizadeh - Nordic journal of psychiatry, 2015 - Taylor & Francis
Background: No published systematic review has ever assessed the efficacy and safety of
reboxetine for treating of patients with attention deficit hyperactivity disorder (ADHD). Aim …
reboxetine for treating of patients with attention deficit hyperactivity disorder (ADHD). Aim …
ADHD with comorbid bipolar disorders: a systematic review of neurobiological, clinical and pharmacological aspects across the lifespan
F Mucci, MT Avella, D Marazziti - Current Medicinal Chemistry, 2019 - ingentaconnect.com
Background: Attention deficit hyperactivity (ADHD) disorder is a neurodevelopmental
disorder characterized by inattention, hyperactivity, disruptive behaviour, and impulsivity …
disorder characterized by inattention, hyperactivity, disruptive behaviour, and impulsivity …
A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder
N Maneeton, B Maneeton, S Intaprasert… - … disease and treatment, 2014 - Taylor & Francis
Background Some trials have suggested that bupropion, as well as methylphenidate, is
beneficial in the treatment of attention‐deficit/hyperactivity disorder (ADHD). Objectives The …
beneficial in the treatment of attention‐deficit/hyperactivity disorder (ADHD). Objectives The …